Salute e Benessere

Nfl Biosciences: Patent Application Filed in the United States for Reducing…

NFL BIOSCIENCES: PATENT APPLICATION FILED IN THE UNITED STATES FOR REDUCING ALCOHOL CONSUMPTION WITH NFL-301 & PREPARATION OF A PRE-IND APPLICATION SUBMISSION WITH THE FDA NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of addictions, is announcing that it has today submitted a patent application in the United States for its drug candidate NFL-301, focused on reducing alcohol consumption. This ...
Nasdaq GlobeNewswire
18/07/2023

Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the…

Until the appointment as Non-Executive Director by the EGM, Dr. Peters will join the Board of Directors as an Observer. Until the appointment as Non-Executive Director by the EGM, Dr. Peters will join the Board of Directors as an Observer. Paul Sekhri, Chairman of the Board, commented: "After an extensive search, the Board is pleased to nominate Dr.Richard Petersas the new Chairman of the Board of Directors. Dr. Peters is a highly respected and proven industry leader, who brings...
PR Newswire
18/07/2023

Press release Biocartis Group NV: Biocartis appoints George Cardoza as new CFO…

PRESS RELEASE - INSIDE INFORMATION/ REGULATED INFORMATION18 July 2023 , 7:00 AM CEST Biocartis appoints George Cardoza as new CFOand Head of Service Delivery George Cardoza appointed as Biocartis' new Chief Financial Officer and Head of Service Delivery .Announced operational reorganization and cost reduction program progressing according to plan . Mechelen, Belgium, 18 July 2023- Biocartis Group NV (the 'Company' or 'Biocartis'),...
Nasdaq GlobeNewswire
18/07/2023

Novartis delivers strong sales growth, robust margin expansion and raises…

Ad hoc announcement pursuant to Art. 53 LRQ2 sales grew +9% (cc 3, +7% USD) with core operating income growing +17% (cc, +9% USD) Innovative Medicines (IM) sales grew +9% (cc, +7% USD) and core operating income +20% (cc, +12% USD), with core margin reaching 39.0%, (+340 bps cc)Growth driven by continued strong performance fromEntresto, Kesimpta, PluvictoandKisqali Sandoz sales grew +8% (cc, +5% USD) and core operating income +6% (cc, -5% USD) Q2…
Nasdaq GlobeNewswire
18/07/2023

Irritable Bowel Syndrome Market to Exhibit Growth at a CAGR of 9.3% During the…

Key Takeaways from the Irritable Bowel Syndrome Market Report Key Takeaways from the Irritable Bowel Syndrome Market Report Discover which therapies are expected to grab the major irritable bowel syndrome market share @Irritable Bowel Syndrome Market Report Irritable Bowel Syndrome Overview Irritable bowel syndrome is a chronic functional bowel disorder characterized by symptoms of stomach pain and discomfort linked with changed bowel habits in the absence of a structural or...
PR Newswire
17/07/2023

Groupe Casino: Update on new money equity offers

Update on new money equity offers Paris, 17 July 2023Casino annouces that it received on 15 July 2023 a revised offer from EP Global Commerce a.s., Fimalac and Attestor to strengthen the Group's equity capital. A presentation of this offer has been posted on Casino's website ( Presentation ). 3F Holding decided not to submit a revised offer.The Group recalls the criteria for assessing the proposals which were made available to the public:Business continuity and long-term viability...
Nasdaq GlobeNewswire
17/07/2023

Endo and Premier, Inc. Collaborate to Address Pitocin® (oxytocin injection, USP)…

Pitocin® is used to induce labor in pregnant women. The product is on the World Health Organization's essential medications list and has a history of supply disruptions, which can result in potential health risks to mothers and babies, as well as costly delays in hospital labor and delivery wards. The partnership involves a multifaceted approach seeking to provide stable product supply through adequate safety stock on a long-term basis. Pitocin ®is used to induce labor in pregnant women...
PR Newswire
17/07/2023

Kingspan Group plc ("Kingspan") announces the acquisition of a majority stake in…

Steico had audited operating revenues of EUR445m in the 12 months to 31 December 2022 and EBITDA of EUR90m in the same period. As at June 2023, Steico guided 2023 revenues of c.EUR378m at an EBIT margin of 8% - 10% (FY22 14.6%). As at 31 December 2022, Steico had gross assets of EUR509m. Steico had audited operating revenues ofEUR445min the 12 months to31 December 2022and EBITDA ofEUR90min the same period. As atJune 2023, Steico guided 2023 revenues of c. EUR378mat an EBIT...
PR Newswire
17/07/2023

Guerbet: Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer

Guerbet winsPI-CAI Grand Challengeon detection of prostate cancer Villepinte, 17 July 2023:Guerbet (FR0000032526 GBT), a global specialist in contrast media and medical imaging solutions, is delighted to announce the success of its teams at thePI-CAI (Prostate Imaging: Cancer Al) Grand Challenge1, an international challenge organised by a consortium 2of radiology opinion leaders in prostate imaging, urologists and artificial intelligence experts, to compare the...
Nasdaq GlobeNewswire
17/07/2023

Press Release: FDA approves Beyfortus™ (nirsevimab-alip) to protect infants…

FDAapprovesBeyfortus™(nirsevimab-alip)toprotect infants against RSV disease Beyfortus™is the first monoclonal antibody approved to protect all infants through their first RSV seasonAcross all clinical endpoints, a single dose ofBeyfortusdelivered high, consistent and sustained efficacy and favorable safety against RSV diseaseApproval also includes use for children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season...
Nasdaq GlobeNewswire
17/07/2023

Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior…

Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025(ISIN: BE6325746855)Liege, Belgium ,17July2023–17:45 CEST– Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the " Company " or " Mithra "), a company dedicated to Women's Health, confirms to Bondholders that, in accordance with the terms and conditions of the Company's EUR 125,000,000 senior unsecured convertible bonds due 2025...
Nasdaq GlobeNewswire
17/07/2023

Breast Lesion Localization Market worth $0.4 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=35768623 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=35768623 Browse in-depth TOC on "Breast Lesion Localization Market"250 - Tables56 - Figures294 - Pages Breast Lesion Localization Market Scope: Wire localization accounted for the largest share of the breast lesion localization market. Based on type, the breast lesion...
PR Newswire
17/07/2023

Writing Instrument Market to Reach $18.1 Billion, Globally, by 2032 at 4.6%…

Download Sample of this report: https://www.alliedmarketresearch.com/request-sample/11211 Download Sample of this report: https://www.alliedmarketresearch.com/request-sample/11211 Prime determinants of growth Growing demand for writing instrument from the corporate sector is boosting the growth of the global writing instrument market during the forecast period. However, one of the main restraints of writing instrument is rapid rise in the use of digital devices such as laptops...
PR Newswire
17/07/2023

Lung Monitoring Devices Market to Reach $6,112.50 million, Globally, by 2032 at…

Request Sample Report on Lung Monitoring Devices Market Analysis 2032. Allied Market Research- https://www.alliedmarketresearch.com/request-sample/12420 Request Sample Report on Lung Monitoring Devices Market Analysis 2032. Allied Market Research- https://www.alliedmarketresearch.com/request-sample/12420 Prime determinants of growth An increase in the prevalence of lung diseases, and the advancement in lung monitoring device products such as the development of hand-held and...
PR Newswire
17/07/2023

Intraoral/IOL Scanners Market worth $1.0 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=15959266 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=15959266 Browse in-depth TOC on "Intraoral/IOL Scanners Market" 70 - Tables 150 - Figures 300 - Pages Intraoral/IOL Scanners Market Scope: "During the forecast period, the wired scanner is expected to be the fastest growing segment of the intraoral scanner market." Under...
PR Newswire
17/07/2023

Sapphiros Appoints Industry Veteran Andrew Garfield to Lead Technology Transfer…

Mark Gladwell, CEO of Sapphiros, commented, "We are excited for Andrew to join our team at Sapphiros. Andrew brings a wealth of experience in high volume, high-complexity manufacturing, leading and scaling multiple operations across Europe and the US. His technical capabilities combined with his process expertise will accelerate the transfer of our product portfolio, including Satio draw and detect technologies, Lateral Flow, Digital Lateral Flow, Molecular and Graphene Biosensor…
PR Newswire
17/07/2023

Essity has exited the Russian market

"Ever since the start of Russia's war against Ukraine, we have been fully focused on exiting Russia. Today, we have completed the divestment of our business following a long and complex process," says Magnus Groth, President and CEO of Essity. "Ever since the start ofRussia'swar againstUkraine, we have been fully focused on exitingRussia. Today, we have completed the divestment of our business following a long and complex process," saysMagnus Groth, President and CEO of…
PR Newswire
17/07/2023

ALZHEIMER'S ASSOCIATION STATEMENT ON DONANEMAB PHASE 3 DATA REPORTED AT AAIC…

The results showed that donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer's disease (either mild cognitive impairment or mild dementia), confirming the company's May 2023 topline data release. At AAIC, we learned: The results showed that donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer's disease (either mild cognitive impairment or mild dementia), confirming the company'sMay 2023...
PR Newswire
17/07/2023

Devyser's NGS products for monitoring of kidney and stem cell transplanted…

The IVDR approved products are One Lambda Devyser Chimerism, for early detection of mixed chimerism in stem cell transplanted patients, and One Lambda Devyser Accept cfDNA, a novel test for the detection of donor-derived cell-free DNA in blood samples from kidney transplant patients. The IVDR approved products are One Lambda Devyser Chimerism, for early detection of mixed chimerism in stem cell transplanted patients, and One Lambda Devyser Accept cfDNA, a novel test for the detection of...
PR Newswire
17/07/2023

DentalMonitoring featured in National Health Service anniversary publication

For the historic book, Celebrating 75 Years of the National Health Service, DentalMonitoring is showcased with an exclusive feature as an example of achievement and progress in the technological and healthcare sphere. For the historic book, Celebrating 75 Years of the National Health Service, DentalMonitoring is showcased with an exclusive feature as an example of achievement and progress in the technological and healthcare sphere. DentalMonitoring, the first remote monitoring solution...
PR Newswire
17/07/2023

Signant Acquires DSG to Enhance Its eClinical Solution Suite for Traditional and…

Signant's leadership team selected DSG based on an extensive diligence of their solution suite, recognizing the opportunities inherent in its key characteristics, including: (1) ease of use – where sites in particular provided positive feedback; (2) operational efficiency – combines rapid study start up times with superior workflow tools and remote source data verification (SDV) capabilities; (3) flexibility – easily accommodates the requirements of the simplest as well as most complex study…
PR Newswire
17/07/2023

Cumulus Neuroscience Presents Data at AAIC 2023 Annual Meeting and Technology…

"Clinic-based biomarkers are effective in tracking disease progression in clinical research but do not scale to support large real-world studies. Purely digital markers are scalable but lack objectivity," said Brian Murphy, PhD, Founder and Chief Scientific Officer of Cumulus. "This interim analysis has provided confirmation that patients living with Alzheimer's are capable and willing to participate in clinical studies that include at-home EEG, and that our platform is…
PR Newswire
17/07/2023

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 17July 2023– On 9 May 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023. Under the...
Nasdaq GlobeNewswire
17/07/2023

Pioneering the Future of Cardiology: PMcardio Joins Forces with Cardiovascular…

PMcardio, a market leader in AI-powered cardiovascular diagnostics, is thrilled to announce a research and development partnership with the Cardiovascular Research Center Aalst, a world-renowned authority in cardiology. The transformative alliance blends PMcardio's state-of-the-art technology with the globally acclaimed clinical expertise of the Aalst Center, aspiring to unlock new dimensions in cardiac care and improve patient outcomes."Bridging the gap between medical technology...
Nasdaq GlobeNewswire
17/07/2023
Altri  Comunicati